Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study

B Diijkshoorn; Daisy Vedder; D.C. Nordström; B. Gudbjørnsson; K Lend; T Uhlig; Gerdur Gröndal; E.A. Haavardsholm; Merete Lund Hetland; M Heiberg; Mikkel Østergaard; K Hørslev-Petersen; Jon Lampa; R. van Vollenhoven; A Antovic; Michael Nurmohamed

Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study

B Diijkshoorn, Daisy Vedder, D.C. Nordström, B. Gudbjørnsson, K Lend, T Uhlig, Gerdur Gröndal, E.A. Haavardsholm, Merete Lund Hetland, M Heiberg, Mikkel Østergaard, K Hørslev-Petersen, Jon Lampa, R. van Vollenhoven, A Antovic, Michael Nurmohamed

Department for Rheumatology and Spine Diseases

Abstract

Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the effects of initial antirheumatic treatments in (very) early RA patients. Therefore our objective was to assess the effects of different initial treatments on hemostatic parameters in patients with early RA.

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	ACR 2022 - Philadelphia Duration: 10 Nov 2022 → 14 Nov 2022

Conference

Conference	ACR 2022
City	Philadelphia
Period	10/11/2022 → 14/11/2022

Cite this

Diijkshoorn, B., Vedder, D., Nordström, D. C., Gudbjørnsson, B., Lend, K., Uhlig, T., Gröndal, G., Haavardsholm, E. A., Hetland, M. L., Heiberg, M., Østergaard, M., Hørslev-Petersen, K., Lampa, J., van Vollenhoven, R., Antovic, A., & Nurmohamed, M. (2022). Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study. Arthritis & Reumatology Vol. 74, number S9, p. 3183. Abstract from ACR 2022, Philadelphia.

Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study. / Diijkshoorn, B; Vedder, Daisy; Nordström, D.C. et al.
2022. Arthritis & Reumatology Vol. 74, number S9, p. 3183 Abstract from ACR 2022, Philadelphia.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Diijkshoorn, B, Vedder, D, Nordström, DC, Gudbjørnsson, B, Lend, K, Uhlig, T, Gröndal, G, Haavardsholm, EA, Hetland, ML, Heiberg, M, Østergaard, M, Hørslev-Petersen, K, Lampa, J, van Vollenhoven, R, Antovic, A & Nurmohamed, M 2022, 'Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study', ACR 2022, Philadelphia, 10/11/2022 - 14/11/2022 pp. Arthritis & Reumatology Vol. 74, number S9, p. 3183.

@conference{e67fedcad9204dd6b9151401ba74ee1f,

title = "Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study",

abstract = "Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the effects of initial antirheumatic treatments in (very) early RA patients. Therefore our objective was to assess the effects of different initial treatments on hemostatic parameters in patients with early RA.",

author = "B Diijkshoorn and Daisy Vedder and D.C. Nordstr{\"o}m and B. Gudbj{\o}rnsson and K Lend and T Uhlig and Gerdur Gr{\"o}ndal and E.A. Haavardsholm and Hetland, {Merete Lund} and M Heiberg and Mikkel {\O}stergaard and K H{\o}rslev-Petersen and Jon Lampa and {van Vollenhoven}, R. and A Antovic and Michael Nurmohamed",

note = "COPECARE; ACR 2022 ; Conference date: 10-11-2022 Through 14-11-2022",

year = "2022",

language = "English",

pages = "Arthritis & Reumatology Vol. 74, number S9, p. 3183",

}

TY - ABST

T1 - Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study

AU - Diijkshoorn, B

AU - Vedder, Daisy

AU - Nordström, D.C.

AU - Gudbjørnsson, B.

AU - Lend, K

AU - Uhlig, T

AU - Gröndal, Gerdur

AU - Haavardsholm, E.A.

AU - Hetland, Merete Lund

AU - Heiberg, M

AU - Østergaard, Mikkel

AU - Hørslev-Petersen, K

AU - Lampa, Jon

AU - van Vollenhoven, R.

AU - Antovic, A

AU - Nurmohamed, Michael

N1 - COPECARE

PY - 2022

Y1 - 2022

N2 - Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the effects of initial antirheumatic treatments in (very) early RA patients. Therefore our objective was to assess the effects of different initial treatments on hemostatic parameters in patients with early RA.

AB - Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the effects of initial antirheumatic treatments in (very) early RA patients. Therefore our objective was to assess the effects of different initial treatments on hemostatic parameters in patients with early RA.

M3 - Conference abstract for conference

SP - Arthritis & Reumatology Vol. 74, number S9, p. 3183

T2 - ACR 2022

Y2 - 10 November 2022 through 14 November 2022

ER -

Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study

Abstract

Conference

Fingerprint

Cite this